UAE Stent Market to Grow with a CAGR of 4.14% through 2031
The expansion of healthcare infrastructure and a supportive regulatory environment are the major drivers of the UAE Stent Market.
According to TechSci Research report, “UAE
Stent Market Industry Size, Share, Trends, Competition,
Opportunity and Forecast, 2021-2031F”, the UAE Stent Market will grow from USD 60.71 Million in 2025 to USD 77.44 Million by 2031 at a 4.14% CAGR. This may be due to collaborations and partnerships among leading companies, which merge individual companies' expertise and strengthen their positions.
The demand for stents is significantly
driven by the increasing popularity and preference for minimally invasive
procedures. Minimally invasive interventions offer several advantages over
traditional surgical methods, contributing to the growing adoption of stent
placement. Minimally
invasive procedures, including stent placement, involve smaller incisions or
entry points compared to traditional surgeries. This results in less trauma to surrounding tissues, leading to shorter hospital stays and faster recovery times for patients. Minimally invasive techniques are associated with a lower
risk of complications, such as infections, bleeding, and postoperative pain.
This makes these procedures more appealing to both patients and healthcare
providers.
Many minimally invasive procedures,
including some stent placements, can be performed on an outpatient basis or
with a short hospital stay. This is convenient for patients and may reduce
healthcare costs associated with prolonged hospitalization. Minimally invasive
procedures often allow for the use of local anesthesia or conscious sedation
instead of general anesthesia. This can be more tolerable for patients,
especially those who may not be suitable candidates for general anesthesia. Smaller
incisions or entry points result in less noticeable scars, thereby improving cosmetic outcomes. This aesthetic benefit is particularly relevant for
patients who are concerned about the appearance of surgical scars.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Stent Market.”
In February 2019, Med Surg
Solutions, an authorized distributor of Gore, proudly sponsored the PAIRS
International Congress held in Dubai from February 27th to March 2nd, 2019. At
the congress, MSS introduced its Conformable GORE® TAG® Thoracic Endoprosthesis
Stent Graft featuring the new ACTIVE CONTROL delivery system. This system
ensures precise control and predictable stent placement for TEVAR. The MSS
booth featured hands-on simulations from the Gore Medical Mastery Series, offering interactive sessions for physicians to gain a comprehensive understanding of
device design.
Supply
chain disruptions pose a significant challenge in the UAE stent market, as
disruptions can impact the availability and distribution of medical devices.
Many
medical device manufacturers source materials and components globally.
Disruptions in the supply chains of key materials or components, whether due to
geopolitical issues, natural disasters, or other factors, can affect stent production. Disruptions in manufacturing facilities, whether caused
by unforeseen events, equipment failures, or workforce issues, can delay stent production. This can result in shortages and impact on
the ability to meet market demand. Transportation disruptions, such as port
closures, shipping delays, or restrictions on international travel, can affect
the timely delivery of stents to distribution centers and healthcare facilities
in the UAE. Changes in regulatory requirements or delays in obtaining necessary
approvals can affect the market release of stents. Compliance challenges
may arise due to evolving regulatory standards or unexpected regulatory
hurdles. Supply chain disruptions can create difficulties in inventory
management. Maintaining adequate stock levels to meet demand while avoiding
overstocking or wastage requires careful planning and coordination. Economic
factors, including currency fluctuations and cost pressures, can impact the
financial stability of manufacturers and suppliers. This, in turn, may affect
the pricing and availability of stents in the market.
UAE Stent Market is
segmented based on Product Type, Material Type, Type, End User, and by region.
Based on the Product
Type, UAE Stent
Market is segmented into Vascular Stents, Non-Vascular Stents. Non-vascular stents are medical devices used in various anatomical structures
outside the vascular system (blood vessels). Unlike vascular stents that are
primarily used to treat conditions related to blood vessels, non-vascular
stents are employed in different regions of the body to address obstructions,
strictures, or other issues in ducts or tubular structures. Gastrointestinal stents
are used in the digestive tract to treat conditions such as colorectal cancer
or esophageal strictures. They help maintain patency in the affected segments of the gastrointestinal tract. Gastrointestinal stents are commonly
used in endoscopic procedures to alleviate obstructions and improve the flow of
food and fluids. Tracheobronchial
stents are utilized in the trachea or bronchi to address obstructions caused by
tumors, inflammation, or other conditions. They help in maintaining open
airways for breathing. Tracheobronchial stents are used in respiratory medicine to relieve airway obstruction and improve respiratory
function.
Based on Region, Abu Dhabi region held the largest share
in the UAE Stent
Market. Government policies and initiatives in
Abu Dhabi, such as those focused on healthcare development or medical research,
can affect the adoption and demand for medical devices, including stents. The
presence of primary healthcare providers, medical device manufacturers, or
distributors specializing in stents in the Abu Dhabi region can contribute to
its dominance in the market. Abu Dhabi hosts major medical events, conferences,
or congresses related to cardiology or interventional procedures, it could lead
to increased awareness and adoption of advanced medical devices, including
stents.
Some of the major companies operating in
the UAE Stent
Market include:
- Medtronic Meta FZ-LLC
- Boston Scientific Corporation UAE
- Becton Dickinson, and Company
- CONMED Corporation UAE
- Stryker ESCS BV
- Abbott Laboratories S. A
- B. Braun Medical Inc
- Terumo Middle East FZE
- Cook Medical UAE
- Vasmed UAE
Download free Sample Report
Customers
can also request 10% free customization on this report.
“Certain areas,
particularly in Dubai, are projected to exert significant demand for Stent. The
growth in the competitive landscape and the presence of well-established
companies in the market, committed to enhance the overall wellbeing of people each
year, are expected to contribute to a remarkable growth of the UAE Stent
Market in the forecast period," said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based Global management consulting firm.
UAE Stent Market Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Product Type (Vascular Stents {Coronary Stents, Peripheral Stents, Naurovascular Stents}, Non-Vascular Stents {Gastrointestinal Stents, Urological Stents, Pulmonary (Airway) Stents}), By Material Type (Metal, Polymer), By Type (Balloon Expandable, Self-Expandable), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), by region, and Competition 2021-2031F, has evaluated the future growth potential of UAE
Stent Market and provides statistics & information on market size, structure,
and future market growth. The report aims to provide innovative market intelligence and support decision-makers in making sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in UAE Stent Market.
Contact
Mr. Ken
Mathews
Techsci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
M:
+13322586602
Email: [email protected]
Website: https://www.techsciresearch.com